Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04447794 · ClinicalTrials.gov registry record · NA
Step Away: Comparing a Chatbot-delivered Alcohol Intervention With a Smartphone App
A NA study, sponsored by University of Alaska Anchorage.
- Completed
- Registry status
- NA
- Development phase
- 191
- Enrollment target
NCT04447794: Completed NA study, sponsored by University of Alaska Anchorage.
NCT04447794 is a NA study that has completed, run by University of Alaska Anchorage. The registered enrollment target is 191 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04447794, a NA study, has completed, sponsored by University of Alaska Anchorage.
- COMPLETED
- Registry status
- NA
- Development phase
- 191 participants
- Enrollment target
Study Summary
A wide gap exists between the number of people needing alcohol treatment and those actually receiving it. This study builds on a previous one that indicated that smartphone-based intervention can help increase the number of people who receive alcohol intervention services and decrease treatment barriers. Improvements to the previously developed app, Step Away, will be made. In addition, a new method of delivering the Step Away intervention via an online, interactive chatbot, will be developed with the goal of improving engagement and effectiveness. Participants will be recruited and outcomes between the two interventions examined to determine if the Step Away chatbot has enhanced user engagement, intervention fidelity and outcome efficacy in comparison to the Step Away app amongst a group of problem drinkers. Participants will also be interviewed to determine their perceptions of both interventions with a view towards understanding barriers to user engagement.
Primary Outcome
The Timeline Followback (TLFB) will be used to gather information on alcohol and drug use. The TLFB method has demonstrated good test-retest reliability and high correlations with prospective daily recording methods for quantifying alcohol use. In the current study, a 30-day online version will be administered at baseline and the 4 month post-intervention follow-up assessment. Online versions of the TLFB have been shown to have high correlations with phone and in-person interviewer administered
Interventions
- BEHAVIORAL Step Away Chatbot
- BEHAVIORAL Step Away App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 191 participants |
| Start Date | 2020-06-02 |
| Est. Completion | 2021-01-06 |
| Phase | NA |
What the finished NCT04447794 record still lists
NCT04447794 is an interventional study that assigns participants to a tested intervention. The registered 191 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which Step Away Chatbot is the first listed.
NCT04447794 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04447794 about?
NCT04447794 is a clinical study titled "Step Away: Comparing a Chatbot-delivered Alcohol Intervention With a Smartphone App". A wide gap exists between the number of people needing alcohol treatment and those actually receiving it. This study builds on a previous one that indicated that smartphone-based intervention can help increase the number of people who receive alcohol intervention services and decrease treatment barr...
What is the current status of trial NCT04447794?
This trial is currently completed. It is a NA study. The enrollment target is 191 participants. The study started on 2020-06-02. Estimated completion is 2021-01-06.
What interventions are being tested in trial NCT04447794?
The interventions under investigation include: Step Away Chatbot (BEHAVIORAL), Step Away App (BEHAVIORAL).
Who is sponsoring clinical trial NCT04447794?
This trial is sponsored by University of Alaska Anchorage, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04447794's enrollment target sits among peer trials
191 574th of 2000 higher than 1,427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04621435 · 191 participants · Phase 1
Imaging of Solid Tumors Using FAP-2286
- NCT06810544 · 191 participants · Phase 1
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI